Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio.

    Zoller H, Schloegl A, Schroecksnadel S, Vogel W, Fuchs D.

    J Interferon Cytokine Res. 2012 May;32(5):216-20. Epub 2011 Dec 22.

    PMID:
    22191466
    [PubMed - in process]
    2.

    The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.

    Malaguarnera M, Vacante M, Bertino G, Neri S, Malaguarnera M, Gargante MP, Motta M, Lupo L, Chisari G, Bruno CM, Pennisi G, Bella R.

    J Interferon Cytokine Res. 2011 Sep;31(9):653-9.

    PMID:
    21923249
    [PubMed - in process]
    3.

    Investigation of interferon-α response by a single amino acid substitution of nonstructural protein 5A in hepatitis C virus-infected patients.

    Noguchi T, Tamori A, Ogura N, Hori Y, Ikeda S, Nishiguchi S.

    J Interferon Cytokine Res. 2011 Aug;31(8):589-99. doi: 10.1089/jir.2010.0128. Epub 2011 Feb 25.

    PMID:
    21348779
    [PubMed - indexed for MEDLINE]
    4.

    IL28B Polymorphism Is Associated with Both Side Effects and Clearance of Hepatitis C During Interferon-Alpha Therapy.

    Lotrich FE, Loftis JM, Ferrell RE, Rabinovitz M, Hauser P.

    J Interferon Cytokine Res. 2010 Dec 6. [Epub ahead of print]

    PMID:
    21133812
    [PubMed - as supplied by publisher]
    Free PMC Article
    5.

    Modulation of serum interleukin-18 concentrations and hepatitis B virus DNA levels during interferon therapy in patients with hepatitis B e-antigen-positive chronic hepatitis B.

    Sylvan SP, Hellstrom UB.

    J Interferon Cytokine Res. 2010 Dec;30(12):901-8. Epub 2010 Oct 25.

    PMID:
    20973680
    [PubMed - indexed for MEDLINE]
    6.

    Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection.

    Vespasiani-Gentilucci U, Galati G, Mazzarelli C, D'Avola D, Spataro S, Gallo P, Rigon A, Pellicelli A, Dicuonzo G, Afeltra A, Picardi A.

    J Interferon Cytokine Res. 2011 Feb;31(2):207-10. Epub 2010 Sep 27.

    PMID:
    20874229
    [PubMed - indexed for MEDLINE]
    7.

    Early interferon-based treatment after detection of persistent hepatitis C virus infection: a critical decision.

    Amador-Cañizares Y, Dueñas-Carrera S.

    J Interferon Cytokine Res. 2010 Nov;30(11):817-24. Epub 2010 Sep 13. Review.

    PMID:
    20836713
    [PubMed - indexed for MEDLINE]
    8.

    Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.

    Pagliaccetti NE, Robek MD.

    J Interferon Cytokine Res. 2010 Aug;30(8):585-90. Review.

    PMID:
    20645875
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C.

    Ramos EL.

    J Interferon Cytokine Res. 2010 Aug;30(8):591-5.

    PMID:
    20645873
    [PubMed - indexed for MEDLINE]
    10.

    Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.

    He XS, Nanda S, Ji X, Calderon-Rodriguez GM, Greenberg HB, Liang TJ.

    J Interferon Cytokine Res. 2010 May;30(5):311-20.

    PMID:
    20038212
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk